BGN4 & BORI 乳酸菌研究所
- Development of allergy-suppressive Bifidobacterium and Lactobacillus.
- Development of rotavirus-inhibiting Bifidobacterium; BORI protein, a novel rotavirus-inhibiting active component, is in pending for patent in USA, Europe, and Japan.
- Development of tumor-suppressive Bifidobacterium; chiro-inositol containing polysaccharide, a novel tumor-suppressive active component, was characterized.
- Development of food-grade vectors for BifidobacteriumMajor Projects
- The effect of Gimchi intake on the microorganism in the intestine of human body.
- Development and commercialization of the physiological active bifidus bacterium that is suitable to the Korean.
- Development of the Bifidus fermented product for strengthening immunity function by using rice and vegetables.
- Development of functional intestinal regulation product by using bacteriosin production lactic bacterium.
- Development of intestinal regulation product for the elderly by using farm produces.
- Searching examination of the immunity active factors inside the intestine that were originated from Bifidobacterium and study on their modes of actions.
- Development of bacteriocin-producing probiotic products.
- Development of food-grade vector for Bifidobacterium.
- Study on food nutrient for preventing chronic disease.
- Isolation and characterization of immno-potentiation and cancer-prevention biomaterials derived from Bifidobacterium-fermented products.
- Development of high quality processed product by using the pleuropterus multflorus, and searching examination about generation and inhibition of oxidized form.
- Enhancement of immunity activation originated from Bifidobacterium and development and industrialization of materials for preventing colorectal cancer Bifidobacterium .
- Production of enzyme of CLA(conjugated linoleic acid), a physiological activation substance.
- Development of high efficient separation and withdrawal process based on production of high functional bifidobacterium.
- Development of the delivery system inside the intestine by using bifidus, and expression of the anti-rotavirus protein.
- Development and industrialization of high functional soybean fermented food by using Rhizopus and Monascus.
- Development of the allergy lowering probiotics product.
- Development of functional food based on bifidus that produces chiro-inositol polysaccharose.
- Tablet formulation and development of product, of anti-rota virus active bifidus and protein(BORI)
- Production of high density bifdobacterium by using the next generations high performance bioreactor and development of technologies for bio-conversion of ginseng extracts.
- Development of the fine vasculature blood circulation improved product by using bio conversion ginseng.
- Industrialization by using Bifidus that produces anti-bacteria active substance.
- Development of functional food based on bifidus that produces cairo-inositol polysaccharose..
- Development of probiotics bacteria that lower sensitive storage, and study on converting them into products.
- Development of difficult-to-expression recombination proteolytic enzyme by using the culture of plant cells.